Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.
Authors: Moghadas SM; Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada., Shoukat A; Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada., Bawden CE; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada., Langley JM; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia, Canada., Singer BH; Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA., Fitzpatrick MC; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, Connecticut, USA., Galvani AP; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, Connecticut, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 May 15; Vol. 78 (5), pp. 1328-1335.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciad658